Latest news

Thumbnail image for US expands reach of Keytruda in NSCLC

US expands reach of Keytruda in NSCLC

US regulators have approved MSD’s Keytruda, in combination with carboplatin and either paclitaxel or nab-paclitaxel, for the first-line treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC).

2nd November 2018

Thumbnail image for FDA advisors turn down Alkermes’ ALKS 5461

FDA advisors turn down Alkermes’ ALKS 5461

Alkermes’ ALKS 5461 has been hit with a potential setback in the US after regulatory advisors failed to back its approval for major depressive disorder (MDD).

2nd November 2018

Thumbnail image for Sanofi buys into Denali’s RIPK1 programme

Sanofi buys into Denali’s RIPK1 programme

Sanofi is linking with Denali Therapeutics on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases.

2nd November 2018

Thumbnail image for GSK narrows earnings guidance after Shingrix boost

GSK narrows earnings guidance after Shingrix boost

GSK says it now expects full-year earnings at the upper end of its guidance after continued sales growth during the third quarter and the delay to generic competition for one of its key products.

1st November 2018

Previous  --   14 15 16 17 18 19 20 21 22 23   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download